These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

165 related articles for article (PubMed ID: 34068217)

  • 1. Discontinuation of Passive Immunization Is Safe after Liver Transplantation for Combined HBV/HDV Infection.
    Ossami Saidy RR; Sud I; Eurich F; Aydin M; Postel MP; Dobrindt EM; Pratschke J; Eurich D
    Viruses; 2021 May; 13(5):. PubMed ID: 34068217
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Transplantation of hepatitis D virus patients: Lifelong hepatitis B immunoglobulins?
    Ferenci P; Reiberger T; Stadlbauer V; Zoller H
    Liver Int; 2023 Aug; 43 Suppl 1():96-100. PubMed ID: 35767373
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Nucleos(t)ide analog(s) prophylaxis after hepatitis B immunoglobulin withdrawal against hepatitis B and D recurrence after liver transplantation.
    Cholongitas E; Goulis I; Antoniadis N; Fouzas I; Imvrios G; Giakoustidis D; Giouleme O; Papanikolaou V; Akriviadis E; Vasiliadis T
    Transpl Infect Dis; 2016 Oct; 18(5):667-673. PubMed ID: 27421122
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Successful clinical and virological outcomes of liver transplantation for HDV/HBV-related disease after long-term discontinuation of hepatitis B immunoglobulins.
    Lenci I; Tariciotti L; Angelico R; Milana M; Signorello A; Manzia TM; Toti L; Tisone G; Angelico M; Baiocchi L
    Clin Transplant; 2023 Jun; 37(6):e14971. PubMed ID: 36928864
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Hepatitis B Virus and Hepatitis D Virus Recurrence in Patients Undergoing Liver Transplantation for Hepatitis B Virus and Hepatitis B Virus Plus Hepatitis D Virus.
    Adil B; Fatih O; Volkan I; Bora B; Veysel E; Koray K; Cemalettin K; Burak I; Sezai Y
    Transplant Proc; 2016; 48(6):2119-23. PubMed ID: 27569956
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Liver transplantation in delta virus infection.
    Roche B; Samuel D
    Semin Liver Dis; 2012 Aug; 32(3):245-55. PubMed ID: 22932973
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Recurrence of Hepatitis D Virus in Liver Transplant Recipients With Hepatitis B and D Virus-Related Chronic Liver Disease.
    Serin A; Tokat Y
    Transplant Proc; 2019 Sep; 51(7):2457-2460. PubMed ID: 31405744
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Evolving experience of hepatitis B virus prophylaxis in liver transplantation.
    Honaker MR; Shokouh-Amiri MH; Vera SR; Alloway RR; Grewal HP; Hardinger KL; Kizilisik AT; Bagous T; Trofe J; Stratta RJ; Egidi MF; Gaber AO
    Transpl Infect Dis; 2002 Sep; 4(3):137-43. PubMed ID: 12421458
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Entecavir and other nucleos(t)ide analogs prophylaxis in hepatitis B virus-related liver transplantation: long-term efficacy and safety.
    Darweesh SK; Gad AA; Akroof K; ElLatif ZA
    Eur J Gastroenterol Hepatol; 2019 May; 31(5):607-612. PubMed ID: 30724767
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Low risk of hepatitis B virus recurrence after withdrawal of long-term hepatitis B immunoglobulin in patients receiving maintenance nucleos(t)ide analogue therapy.
    Wong SN; Chu CJ; Wai CT; Howell T; Moore C; Fontana RJ; Lok AS
    Liver Transpl; 2007 Mar; 13(3):374-81. PubMed ID: 17318855
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Hepatitis B Immunoglobulin discontinuation in long-term liver transplant patients.
    Dobrindt EM; Keshi E; Salim Y; Gillespie A; Saipbaev A; Schöning W; Öllinger R; Pratschke J; Eurich D
    Transpl Infect Dis; 2020 Aug; 22(4):e13303. PubMed ID: 32367631
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Hepatitis B prophylaxis post liver transplantation with newer nucleos(t)ide analogues after hepatitis B immunoglobulin discontinuation.
    Cholongitas E; Vasiliadis T; Antoniadis N; Goulis I; Papanikolaou V; Akriviadis E
    Transpl Infect Dis; 2012 Oct; 14(5):479-87. PubMed ID: 22624695
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Role of lamivudine in the posttransplant prophylaxis of chronic hepatitis B virus and hepatitis delta virus coinfection.
    Caccamo L; Agnelli F; Reggiani P; Maggi U; Donato MF; Gatti S; Paone G; Melada E; Rossi G
    Transplantation; 2007 May; 83(10):1341-4. PubMed ID: 17519784
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Tenofovir/entecavir monotherapy after hepatitis B immunoglobulin withdrawal is safe and effective in the prevention of hepatitis B in liver transplant recipients.
    Fernández I; Loinaz C; Hernández O; Abradelo M; Manrique A; Calvo J; Manzano M; García A; Cambra F; Castellano G; Jiménez C
    Transpl Infect Dis; 2015 Oct; 17(5):695-701. PubMed ID: 26257166
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Prophylaxis against hepatitis B virus recurrence after liver transplantation: a registry study.
    Shen S; Jiang L; Xiao GQ; Yan LN; Yang JY; Wen TF; Li B; Wang WT; Xu MQ; Wei YG
    World J Gastroenterol; 2015 Jan; 21(2):584-92. PubMed ID: 25593480
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Transplantation of hepatitis B surface antigen-positive livers into hepatitis B virus-positive recipients and the role of hepatitis delta coinfection.
    Franchello A; Ghisetti V; Marzano A; Romagnoli R; Salizzoni M
    Liver Transpl; 2005 Aug; 11(8):922-8. PubMed ID: 16035057
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Efficacy of Newer Nucleos(t)ide Analogs After Hepatitis B Immunoglobulin Discontinuation Against Hepatitis B and D Recurrence in Liver Transplant Recipients.
    Cholongitas E; Oikonomou T; Bafa K; Sinakos E; Papatheodoridis GV; Goulis I
    Transplantation; 2024 Sep; 108(9):e239-e244. PubMed ID: 38557857
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Minimization of anti-hepatitis B surface antigen immunoglobulins for prophylaxis of hepatitis B viral recurrence in the first month after liver transplantation: the meaning of HBsAg quantitative level at the time of transplant.
    Tandoi F; Nada E; Pittaluga F; Fop F; Lupo F; Romagnoli R; Salizzoni M
    Transplant Proc; 2014 Sep; 46(7):2308-11. PubMed ID: 25242775
    [TBL] [Abstract][Full Text] [Related]  

  • 19. The role of HBIG in real life for patients undergoing liver transplantation due to HDV-related cirrhosis.
    Rodríguez-Tajes S; García-Eliz M; Marcos AC; Campos-Varela I; Ros AC; Loinaz C; Gómez Bravo MÁ; Rodríguez-Perálvarez M; Fabrega E; González Diéguez ML; Vinaixa C; Pascasio JM; Vázquez IF; Baliellas C; Castells L; Salcedo M; Prieto M; Crespo G; Lens S; Forns X
    Liver Int; 2024 Feb; 44(2):279-285. PubMed ID: 38100141
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Discontinuation of Hepatitis B Immunoglobulin by Long-term Hepatitis B Vaccine Inoculation in Preventing Hepatitis B Recurrence After Liver Transplantation.
    Usui M; Sugimoto K; Kato H; Murata Y; Tanemura A; Kuriyama N; Azumi Y; Kishiwada M; Mizuno S; Sakurai H; Takei Y; Isaji S
    Transplant Proc; 2016 May; 48(4):1179-83. PubMed ID: 27320582
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.